Literature DB >> 7102656

Trends in the incidence of cancer of the corpus uteri in Connecticut, 1964-1979, in relation to consumption of exogenous estrogens.

L D Marrett, J W Meigs, J T Flannery.   

Abstract

The incidence of cancer of the uterine corpus diagnosed in the localized 1964 and 1969. During the next six years, however, it increased substantially, reaching a peak in 1975, followed by an irregular decline through 1979. Women aged 45-64 years showed both the largest increase and the sharpest decline. The incidence of tumors diagnosed with regional or distant spread has been rising slightly but consistently through the period 1970-1979; this upward trend is statistically significant (p less than 0.01). Rates corrected for hysterectomized women not truly at risk are 40-50% higher than uncorrected rates but trends are the same. Explanations which are considered are changes in diagnostic practices and changes in risk factor prevalence. The use of noncontraceptive oral estrogens, a well documented risk factor for endometrial cancer, increased between 1964 and 1975 and then declined sharply through 1979 in the United States. The importance of these compounds in explaining the observed incidence trends is considered in terms of the major time- and stage-specific features of the exogenous estrogen-endometrial cancer association reported in the case-control studies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7102656     DOI: 10.1093/oxfordjournals.aje.a113402

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Trends in endometrial cancer incidence and mortality in Sweden, 1960-84.

Authors:  I Persson; M Schmidt; H O Adami; R Bergstrøm; B Pettersson; P Sparén
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

2.  Recent time trends in uterine cancer.

Authors:  V Persky; F Davis; R Barrett; E Ruby; C Sailer; P Levy
Journal:  Am J Public Health       Date:  1990-08       Impact factor: 9.308

3.  Are women using postmenopausal estrogens? A community survey.

Authors:  R B Harris; A Laws; V M Reddy; A King; W L Haskell
Journal:  Am J Public Health       Date:  1990-10       Impact factor: 9.308

4.  Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89.

Authors:  F Jin; X O Shu; S S Devesa; W Zheng; W J Blot; Y T Gao
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

5.  Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.

Authors:  Timothy R Rebbeck; Angela DeMichele; Teo V Tran; Saarene Panossian; Greta R Bunin; Andrea B Troxel; Brian L Strom
Journal:  Carcinogenesis       Date:  2008-11-20       Impact factor: 4.944

6.  Risk factors of female cancers in Ragusa population (Sicily)--1. Endometrium and cervix uteri cancers.

Authors:  R Cusimano; G Dardanoni; L Dardanoni; M La Rosa; G Pavone; R Tumino; L Gafà
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

Review 7.  Estrogen replacement therapy (ERT) in high-risk cancer patients.

Authors:  K A Hutchinson-Williams; J N Gutmann
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.